Cardlytics, Inc. (NASDAQ:CDLX) Receives Average Recommendation of “Hold” from Brokerages

Shares of Cardlytics, Inc. (NASDAQ:CDLX) have earned an average rating of “Hold” from the seven ratings firms that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a strong buy rating to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $6.92.

CDLX has been the topic of a number of recent analyst reports. Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a report on Friday, January 17th. Craig Hallum upgraded shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a report on Wednesday, November 6th.

Insider Buying and Selling at Cardlytics

In other Cardlytics news, CFO Alexis Desieno sold 8,854 shares of the company’s stock in a transaction on Friday, January 3rd. The shares were sold at an average price of $3.67, for a total value of $32,494.18. Following the transaction, the chief financial officer now directly owns 121,976 shares in the company, valued at $447,651.92. The trade was a 6.77 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Amit Gupta sold 15,160 shares of the company’s stock in a transaction on Friday, January 24th. The shares were sold at an average price of $3.92, for a total transaction of $59,427.20. Following the completion of the transaction, the chief executive officer now owns 215,494 shares in the company, valued at approximately $844,736.48. This represents a 6.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 111,454 shares of company stock worth $391,864 over the last ninety days. Insiders own 4.40% of the company’s stock.

Institutional Investors Weigh In On Cardlytics

Institutional investors and hedge funds have recently bought and sold shares of the company. Tallon Kerry Patrick bought a new stake in Cardlytics during the fourth quarter worth about $37,000. Atom Investors LP bought a new stake in Cardlytics during the third quarter worth about $33,000. ProShare Advisors LLC bought a new stake in Cardlytics during the fourth quarter worth about $43,000. SG Americas Securities LLC bought a new stake in Cardlytics during the third quarter worth about $45,000. Finally, Intech Investment Management LLC bought a new stake in Cardlytics during the third quarter worth about $47,000. Institutional investors own 68.10% of the company’s stock.

Cardlytics Price Performance

Shares of CDLX opened at $2.63 on Monday. The company has a market cap of $133.66 million, a price-to-earnings ratio of -0.43 and a beta of 1.54. Cardlytics has a 1-year low of $2.44 and a 1-year high of $20.52. The company’s fifty day simple moving average is $3.34 and its 200 day simple moving average is $3.61. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.